Emerge Diagnostics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 10

Emerge Diagnostics General Information

Description

Manufacturer of diagnostic devices intended to assist in the diagnosis and treatment of workplace injuries with a focus on musculoskeletal disorders. The company's device determines the location and age of soft tissue injuries and evaluates muscle activity, distinguishes between acute versus chronic injury and objectively quantifies effort, enabling clients to get accurate results and get better faster.

Contact Information

Formerly Known As
OKTX
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 5840 El Camino Real
  • Suite 102
  • Carlsbad, CA 92008
  • United States
+1 (760) 000-0000

Emerge Diagnostics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emerge Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Emerge Diagnostics‘s full profile, request access.

Request a free trial

Emerge Diagnostics Patents

Emerge Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110224503-A1 Electro diagnostic functional assessment unit (efa-3) Active 12-Mar-2010 0000000000 00
US-8568312-B2 Electro diagnostic functional assessment unit (efa-3) Inactive 12-Mar-2010 0000000000 00
US-8535224-B2 Electro diagnostic functional assessment unit (efa-2) Active 18-Feb-2010 00000000 00
US-20110201904-A1 Electro diagnostic functional assessment unit (efa-2) Active 18-Feb-2010 00000000 00
US-8117047-B1 Healthcare provider organization Active 16-Apr-2007 G16H40/20 00
To view Emerge Diagnostics’s complete patent history, request access »

Emerge Diagnostics Executive Team (7)

Name Title Board Seat Contact Info
David Saunders Co-Chief Executive Officer & President
MaryRose Reaston Ph.D Co-Founder & Chief Scientific Officer
Bret Oettmeier Co-Chief Executive Officer
Ron McNair Chief Financial Officer
Murray Lappe MD Medical Director & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Emerge Diagnostics Board Members (11)

Name Representing Role Since
00000 00000 Self Board Member 000 0000
00000 00000000 Self Board Member 000 0000
0000 0000000 Pacific Growth Investors Board Member 000 0000
0000000 000000 Emerge Diagnostics Board Member 000 0000
000000 00000 00 Self Medical Director & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Emerge Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emerge Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Emerge Diagnostics‘s full profile, request access.

Request a free trial